Human Genome Epidemiology Literature Finder
Records 1 - 10 (of 10 Records) |
Query Trace: Dyspepsia and CYP2C19[original query] |
---|
The prevalence of CYP2C19 mutations in Turkish patients with dyspepsia. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2009 Sep 20 (3): 161-4. Celebi Altay, Kocaman Orhan, Savli Hakan, Aygün Cem, Konduk Bu?ra Tolga, Sentürk Omer, Hülagu Sadett |
Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects. Journal of clinical pharmacy and therapeutics 2010 Jun 35 (3): 343-50. Lee V W Y, Chau T S, Chan A K W, Lee K K C, Waye M M Y, Ling T K W, Chan F K |
Genetic Polymorphisms of Cytochrome P450 2C19 in Functional Dyspeptic Patients Treated with Cimetidine. The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 2012 Oct 16 (5): 339-42. Kim Minhee, Kong Eunh |
Modified sequential Helicobacter pylori eradication therapy using high dose omeprazole and amoxicillin in the initial phase in the extensive metaboliser Turkish patients for CYP2C19 polymorphism is ineffective. Acta gastro-enterologica Belgica 2014 Mar 77 (1): 3-7. Sezgin Orhan, Barlas I Omer, Uçbilek Enver, Yengel Emre, Altinta? Eng |
Influence of CYP2C19 on Helicobacter pylori eradication in Brazilian patients with functional dyspepsia. Genetics and molecular research : GMR 2016 Sep 15 (3): . Nabinger D D, Mazzoleni L E, Sander G B, Mazzoleni F, Osório M C, Klein M G, Rech T F, Basso da Silva L, de Moraes G S, Cristovam R A, Nardelli E F, Francesconi C F M, Simon |
Effects of CYP2C19*17 polymorphisms on the efficacy and safety of bromodigyrochlorophenylbenzodiazepine in patients with anxiety disorder and comorbid alcohol use disorder. Drug metabolism and personalized therapy 2018 12 33 (4): 187-194. Zastrozhin Michael S, Antonenko Anastasiya P, Nesterenko Elena V, Seyfullaeva Leyla I, Mustafina Violetta R, Esakova Antonina P, Grishina Elena A, Sorokin Alexandr S, Skryabin Valentin Yu, Savchenko Ludmila M, Bryun Evgeny A, Sychev Dmitry |
[Dual therapy with rabeprazole and amoxicillin four times daily for 14 days for the first-line eradication of Helicobacter pylori infection]. Zhonghua yi xue za zhi 2019 12 99 (48): 3781-3785. Suo B J, Tian X L, Li C L, Song Z |
Prevalence of CYP2C19 polymorphism in Bogotá, Colombia: The first report of allele *17. PloS one 2021 16 (1): e0245401. Arévalo-Galvis Azucena, Otero-Regino William A, Ovalle-Celis Gloria N, Rodríguez-Gómez Eliana R, Trespalacios-Rangel Alba |
Predictive modeling of adverse drug reactions to tamoxifen therapy for breast cancer on base of pharmacogenomic testing. Drug metabolism and personalized therapy 2023 7 . Ekaterina Olegovna Golubenko, Marina Ivanovna Savelyeva, Zhannet Alimovna Sozaeva, Vera Vyacheslavovna Korennaya, Irina Vladimirovna Poddubnaya, Timur Tejmurazovich Valiev, Svetlana Nikolaevna Kondratenko, Mikhail Vitalyevich Ily |
Most patients with disorders of gut-brain interaction receive pharmacotherapy with major or moderate drug-gene interactions. Neurogastroenterology and motility 2023 12 e14722. Revati Varma, Jeffrey P Staab, Eric T Matey, Jessica A Wright, Brototo Deb, Konstantinos N Lazaridis, Lawrence A Szarka, Kent R Bailey, Adil E Bharuc |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: